Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, Highlights Key Reasons to Attend OPC 2025
June 16th 2025Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, co-chair of the 2025 Oncology Pharmacists Connect (OPC) meeting, discusses what makes the event unique, highlights key sessions, and shares her excitement for the educational and networking opportunities.
Read More
Psychedelic Science 2025: Clinical Perspectives on Psychedelics in Palliative Oncology
June 16th 2025Manish Agrawal, MD, discusses emerging research on psychedelic-assisted therapy for patients with cancer, including innovative dyadic treatment models, challenges in capturing meaningful outcomes, and growing interest in integrating psychedelics into oncology and palliative care.
Watch
Expert: Strategies for CIDP Medication Adherence and Emerging Treatment Innovations
June 14th 2025Amy Duong, PharmD, BCACP, explains pharmacists' critical role in promoting chronic inflammatory demyelinating neuropathy (CIDP) treatment adherence and staying informed about new therapeutic developments.
Watch
Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Published: June 12th 2025 | Updated: June 16th 2025New research reveals how individual blood sugar responses to carbohydrates vary, highlighting the importance of personalized dietary approaches for diabetes management.
Read More
You Shall Not Pass: Pharmacist Review of Drug-Herb Interactions in Cancer Treatment
This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Read More